Bartsch, Rupert
Hilbe, Wolfgang
Article History
Accepted: 9 August 2022
First Online: 9 September 2022
Conflict of interest
: R. Bartsch: Advisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen. Lecture Honoraria: Astra-Zeneca, Daichi, Eli-Lilly, Gilead, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen. Research Support: Daiichi, MSD, Novartis, Roche. W. Hilbe declare that he has no competing interests.
Free to read: This content has been made available to all.